~ Agreement grants VectorY the exclusive right to evaluate and license Shape’s non-invasive, deep-brain penetrating AAV5-derived capsid for vectorized antibodies against three targets ~ ~ License will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback